Skip to main content
Previous
Poster Home
Next
Real-World Clinical Outcomes in Patients With Advanced/Metastatic Melanoma and Brain Metastases Treated With Pembrolizumab Monotherapy – An Analysis of the ADOReg German Skin Cancer Registry
07:30am - 03:35pm EST - April 6, 2024
Information
Resources
Abstract: JNCCN23-0663
https://jnccn.org/view/journal...
Author(s):
Ruixuan Jiang, PharmD, PhD
, Merck & Co Inc.
Tags:
Outcomes and Health Services Research
Display Label
Action